Cargando…
Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
PF-1355 is an oral myeloperoxidase (MPO) inhibitor that successfully decreased elevated MPO activity in mouse myocardial infarction models. Short duration PF-1355 treatment for 7 days decreased the number of inflammatory cells and attenuated left ventricular dilation. Cardiac function and remodeling...
Autores principales: | Ali, Muhammad, Pulli, Benjamin, Courties, Gabriel, Tricot, Benoit, Sebas, Matthew, Iwamoto, Yoshiko, Hilgendorf, Ingo, Schob, Stefan, Dong, Anping, Zheng, Wei, Skoura, Athanasia, Kalgukar, Amit, Cortes, Christian, Ruggeri, Roger, Swirski, Filip K., Nahrendorf, Matthias, Buckbinder, Leonard, Chen, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113523/ https://www.ncbi.nlm.nih.gov/pubmed/30167547 http://dx.doi.org/10.1016/j.jacbts.2016.09.004 |
Ejemplares similares
-
Measuring Myeloperoxidase Activity in Biological Samples
por: Pulli, Benjamin, et al.
Publicado: (2013) -
Myeloperoxidase PET Imaging Tracks Intracellular and Extracellular Treatment Changes in Experimental Myocardial Infarction
por: Zeller, Matthias W. G., et al.
Publicado: (2023) -
Lp-PLA(2) Antagonizes Left Ventricular Healing After Myocardial Infarction by Impairing the Appearance of Reparative Macrophages
por: He, Shun, et al.
Publicado: (2015) -
Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition
por: Roth Flach, Rachel J., et al.
Publicado: (2019) -
Folate Receptor: A Macrophage “Achilles' Heel”?
por: Hilgendorf, Ingo, et al.
Publicado: (2012)